MedVi vs TMates: Semaglutide pricing, support, and access
MedVi vs TMates: both sell clinically dosed compounded semaglutide, but they target different priorities. Quick verdict: choose MedVi for the lowest promotional entry price and a no-clinic, simple online path; choose TMates for predictable flat pricing and 24/7 access to U.S.-based doctors across all 50 states.
How they differ: price structure and ongoing cost
MedVi advertises a winter promotional first-month price of $179 including fast, free shipping, then notes the standalone month rises to $299 and a three-month plan is $649 (about $216/month). TMates advertises a flat $199/month at every dose with no step-up fees as dosage escalates. That makes MedVi the lower-cost entry point but TMates more predictable across titration.
Clinician access and oversight
Both platforms describe clinician review and virtual oversight, but their emphasis differs. MedVi highlights 24/7 support from certified medical professionals via its telehealth program and an online clinician review without clinic visits. TMates emphasizes 24/7 access to U.S.-based doctors, not just messaging, and virtual check-in appointments with licensed coverage in all 50 states.
Medications, formulation, and regulatory notes
Both MedVi and TMates offer compounded semaglutide formulated with the same active ingredient as branded GLP-1s. MedVi states its compounded semaglutide is clinically dosed and produced in FDA-regulated facilities but repeatedly notes compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality. TMates likewise confirms its medication is compounded and not an FDA-approved finished product and highlights U.S.-based formulation facilities.
Availability, shipping, and process
MedVi promotes a fully online intake with no clinic visits and fast, free shipping for the promotional month. TMates offers free shipping as well, says it ships to most states, and stresses licensed coverage in all 50 states with cancel-anytime language and virtual check-ins. Both platforms require a clinician review and state medication availability is subject to medical eligibility and clinician decision.
Direct comparison table
| Criteria | MedVi | TMates |
|---|---|---|
| Starting price | $179 first month (promo) | $199/month flat |
| Ongoing pricing | $299 standalone month; 3-mo $649 (~$216/mo) | $199/month at every dose, no step-up fees |
| Clinician access | 24/7 certified medical support; online clinician review | 24/7 U.S.-based doctors; virtual check-ins |
| Medication type | Clinically dosed compounded semaglutide | Clinically dosed compounded semaglutide; formulated in U.S. facilities |
| Clinic visits required | No clinic visits required | Telehealth with virtual check-ins; licensed coverage in all 50 states |
| Regulatory note | Compounded meds not FDA-approved | Compounded meds not FDA-approved |
Distinctive differences to weigh
Price model: MedVi offers a lower promotional entry price but signals a higher ongoing month-to-month rate unless a multi-month plan is chosen. TMates offers a flat $199/month that does not increase with dose escalation.
Clinician model: MedVi markets 24/7 certified medical support within a streamlined online process and no clinic visits. TMates emphasizes around-the-clock access to U.S.-based doctors and licensed coverage in all 50 states and includes virtual check-ins for ongoing oversight.
Formulation transparency: TMates specifically calls out U.S.-based formulation facilities. MedVi states compounded semaglutide is produced in FDA-regulated facilities and repeats regulatory cautions about compounded medications not being FDA-approved.
What the providers say about outcomes and limits
MedVi includes self-reported patient data references and cautions that results vary and compounded medications are not FDA-reviewed. TMates describes program aims and patient anecdotes but does not supply standardized outcome guarantees. Both platforms state medication prescriptions are subject to clinician review and medical eligibility.
Conclusion and recommendation
Both MedVi and TMates provide clinically dosed compounded semaglutide with telehealth oversight and free shipping. For budget-minded starters who want the lowest advertised entry cost and a no-clinic path, MedVi’s $179 promotional first month may be most attractive. For people who prefer steady predictable pricing at every dose and explicit 24/7 access to U.S.-based doctors across all 50 states, TMates is the clearer match.
Start TMates with flat $199/mo
Choose MedVi if…
You want the lowest promotional first-month price, a simple online intake with no clinic visits, compounded semaglutide, and 24/7 certified medical support.
Choose TMates if…
You prefer predictable flat pricing at every dose, 24/7 access to U.S.-based doctors, licensed coverage in all 50 states, and U.S.-formulated medications.